Daily Newsletter

11 September 2023

Daily Newsletter

11 September 2023

Greater Western Sydney gets $1.9bn allocation for hospital projects

The investment is said to be one of the largest healthcare infrastructure investments in the region's recent history.

September 11 2023

Australia's New South Wales (NSW) Government has earmarked A$3bn ($1.93bn) in the budget for hospital upgrades and construction in Greater Western Sydney.

This investment is said to be one of the largest healthcare infrastructure investments in the region's recent history.

The budget includes A$400m ($257.65m) for the construction of the A$700m ($450.88m) Rouse Hill Hospital, the first new adult public hospital in Western Sydney in over 40 years.

It will be equipped with emergency, maternity, ambulatory, outpatient care, and medical imaging services.

Other investments include A$550m ($354.27m) for Fairfield Hospital, A$350m ($225.44m) for Canterbury Hospital, A$1.3bn ($837.36m) to build the Bankstown-Lidcombe Hospital, and A$120m ($77.29m) for additional beds at Blacktown and Mt Druitt Hospitals.

These investments aim to add 600 new hospital beds in Greater Western Sydney, addressing healthcare challenges caused by years of neglect.

NSW health minister Ryan Park said: “Families living across Greater Western Sydney have a right to timely, equitable healthcare and they should have confidence in their local hospitals.”

“That’s why we’re committed to delivering the essential services our community deserves and expects all while building the healthcare infrastructure to meet the needs of these growing communities into the future.

“This is all part of our ambitious and comprehensive plan to invest in the state’s healthcare system and support and increase our frontline healthcare workforce.”

Is it time for the healthcare sector to fully embrace the benefits of digitalization and AI?

Primarily due to COVID-19, the healthcare sector has witnessed an acceleration in digital transformation, which has improved efficiencies and enhanced patient outcomes. AI can revolutionize the drug discovery process and significantly reduce the time and cost to get a drug to market, particularly in areas of unmet need. There is also huge potential for AI in medical diagnostics. However, using healthcare data for AI development raises data privacy concerns, thereby limiting its adoption.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close